spr_logo.png
SPR® Therapeutics Debuts New SPRINT® PNS Data for Low Back, Shoulder, Knee, and Headache at the 23rd Annual ASRA Pain Medicine Meeting
21 nov. 2024 08h00 HE | SPR Therapeutics, Inc.
SPR Therapeutics announced eight scientific abstracts that will be presented at the upcoming ASRA Pain Medicine Meeting
EarthFlow_Logo_Transparent.png
EarthFlow LLC Announces Launch of New Grounding Website
20 nov. 2024 09h00 HE | EarthFlow LLC
Cheyenne, WY, Nov. 20, 2024 (GLOBE NEWSWIRE) -- EarthFlow LLC is excited to announce the launch of its new grounding website. The website offers a variety of premier products at cost-effective...
factMR-logo.png
Post-Herpetic Neuralgia Treatment Market Projected to Reach $1.38 Billion by 2034, Growing at a CAGR of 5.3% | Fact.MR Report
04 nov. 2024 07h30 HE | FACT.MR
Rockville, MD, Nov. 04, 2024 (GLOBE NEWSWIRE) -- The global post herpetic neuralgia treatment market is calculated to reach a size of US$ 822.4 million in 2024 and climb to US$ 1.38 billion by the...
logo 600X600.png
Over The Counter Pain Medication Market to Surpass $35.50 Billion by 2031, Says Coherent Market Insights (CMI)
19 sept. 2024 11h08 HE | CMI
Burlingame, Sept. 19, 2024 (GLOBE NEWSWIRE) -- The global Over The Counter Pain Medication Market Size to Grow from USD 27.12 Billion in 2024 to USD 35.50 Billion by 2031, at a Compound Annual...
MVAC 2024
Third Annual Hiking Event Brings Awareness to Chronic Pain in Canadian Veterans HAMILTON, Ontario, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Nine Canadian military Veterans living with chronic pain from across Canada completed the third annual Military Veterans Alpine Challenge (Alpine...
PAINWeek Heads to La
PAINWeek Heads to Las Vegas, September 3-6, as the Largest and Most Innovative Pain Management Conference for Frontline Healthcare Professionals
31 juil. 2024 11h00 HE | PAINWeek
Boca Raton, FL, July 31, 2024 (GLOBE NEWSWIRE) -- Building on the momentum of a record-breaking year, PAINWeek, produced by Informa Connect, unveils details of the 18th annual conference. This year,...
finacialnews-logo-final-01 (2).png
Global Fibromyalgia Treatment Market Projected To Reach $3.86 Billion By 2031 as Positive Growth Trends Expected
25 juil. 2024 08h30 HE | FN Media Group LLC
PALM BEACH, Fla., July 25, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The fibromyalgia treatment market has witnessed positive growth trends over the past few years. There is higher...
Curonix-PrimaryLogo_CMYK.png
Curonix Receives the First Full-Body Peripheral Nerve Stimulator (PNS) FDA Clearance, including Craniofacial Pain Indication, for its Freedom® PNS System
09 juil. 2024 08h00 HE | Curonix LLC
Curonix Receives the First Full-Body Peripheral Nerve Stimulator (PNS) FDA Clearance, including Craniofacial Pain Indication, for its Freedom® PNS System.
84bd90f5-4a1f-42a8-8eb1-5cb062a0b6ac.png
Opioids Market to Soar to USD 29.5 Billion by 2033 | Driven by Chronic Pain Prevalence and Increasing Surgical Procedures
13 févr. 2024 07h23 HE | Market.Us
New York, Feb. 13, 2024 (GLOBE NEWSWIRE) -- According to Market.us, the Global Opioids Market size is projected to exceed USD 29.5 Billion by 2033, with a promising CAGR of 2.9% from 2024 to 2033. ...
Logo.png
Chronic Pain Market is Expected to Showcase a Significant Growth by 2032, Predicts DelveInsight | Key Players - Paradigm Biopharmaceuticals, Noven Pharmaceuticals, Pfizer, Biogen, Tonix Pharmaceuticals, Amzell, Bayer, and Others
07 févr. 2024 13h00 HE | DelveInsight Business Research LLP
New York, USA, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Chronic Pain Market is Expected to Showcase a Significant Growth by 2032, Predicts DelveInsight | Key Players - Paradigm Biopharmaceuticals, Noven...